Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanomaMCLEAN, Nicolas; TIGHIOUART, Mourad; MULLER, Susan et al.Oral oncology (1997). 2008, Vol 44, Num 11, pp 1039-1046, issn 1368-8375, 8 p.Article

A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trialsZHENGJIA CHEN; KRAILO, Mark D; AZEN, Stanley P et al.Contemporary clinical trials. 2010, Vol 31, Num 5, pp 473-482, issn 1551-7144, 10 p.Article

Translation of innovative designs into phase I trialsROGATKO, André; SCHOENECK, David; JONAS, William et al.Journal of clinical oncology. 2007, Vol 25, Num 31, pp 4982-4986, issn 0732-183X, 5 p.Article

LOCALIZATION-SPECIFIC LKB1 LOSS IN HEAD AND NECK SQUAMOUS CELL CARCINOMA METASTASISKLINE, Erik R; MULLER, Susan; LIN PAN et al.Head & neck. 2011, Vol 33, Num 10, pp 1501-1512, issn 1043-3074, 12 p.Article

Epithelioid Hemangioendothelioma of Soft Tissue : A Proposal for Risk Stratification Based on 49 CasesDEYRUP, Andrea T; TIGHIOUART, Mourad; MONTAG, Anthony G et al.The American journal of surgical pathology. 2008, Vol 32, Num 6, pp 924-927, issn 0147-5185, 4 p.Article

Sporadic Cutaneous Angiosarcomas : A Proposal for Risk Stratification Based on 69 CasesDEYRUP, Andrea T; MCKENNEY, Jesse K; TIGHIOUART, Mourad et al.The American journal of surgical pathology. 2008, Vol 32, Num 1, pp 72-77, issn 0147-5185, 6 p.Article

Peripheral Blood Monitoring of Chronic Myeloid Leukemia During Treatment With Imatinib, Second-Line Agents, and BeyondLIMA, Lisa; BERNAL-MIZRACHI, Leon; KHOURY, Hanna Jean et al.Cancer. 2011, Vol 117, Num 6, pp 1245-1252, issn 0008-543X, 8 p.Article

EXAMINING EXPRESSION OF FOLATE RECEPTOR IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK AS A TARGET FOR A NOVEL NANOTHERAPEUTIC DRUGSABA, Nabil F; XU WANG; MÜLLER, Susan et al.Head & neck. 2009, Vol 31, Num 4, pp 475-481, issn 1043-3074, 7 p.Article

Insulin-like Growth Factor-l-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer CellsGRAHAM, Tisheeka R; ZHAU, Haiyen E; ODERO-MARAH, Valerie A et al.Cancer research (Baltimore). 2008, Vol 68, Num 7, pp 2479-2488, issn 0008-5472, 10 p.Article

Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted miceHURWITZ, Selwyn J; HONGZHENG ZHANG; KOENIG, Lydia et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 3, pp 577-590, issn 0344-5704, 14 p.Article

The Pivotal Role of Integrin β1 in Metastasis of Head and Neck Squamous Cell CarcinomaDONGSHENG WANG; MÜLLE, Susan; TIGHIOUART, Mourad et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4589-4599, issn 1078-0432, 11 p.Article

Phase 1 and Pharmacokinetic Study of Everolimus, a Mammalian Target of Rapamycin Inhibitor, in Combination With Docetaxel for Recurrent/Refractory Nonsmall Cell Lung CancerRAMALINGAM, Suresh S; HARVEY, R. Donald; HAIAN FU et al.Cancer. 2010, Vol 116, Num 16, pp 3903-3909, issn 0008-543X, 7 p.Article

Distinctive E-cadherin and Epidermal Growth Factor Receptor Expression in Metastatic and Nonmetastatic Head and Neck Squamous Cell Carcinoma : Predictive and Prognostic CorrelationMULLER, Susan; LING SU; TIGHIOUART, Mourad et al.Cancer. 2008, Vol 113, Num 1, pp 97-107, issn 0008-543X, 11 p.Article

BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear LocalizationVENTII, Karen H; DEVI, Narra S; FRIEDRICH, Kenneth L et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 17, pp 6953-6962, issn 0008-5472, 10 p.Article

SEQUENCE DEPENDENCE OF CELL GROWTH INHIBITION BY EGFR-TYROSINE KINASE INHIBITOR ZD1839, DOCETAXEL, AND CISPLATIN IN HEAD AND NECK CANCERKLASS, Carmen M; MI SUN CHOE; HURWITZ, Selwyn J et al.Head & neck. 2009, Vol 31, Num 10, pp 1263-1273, issn 1043-3074, 11 p.Article

A Phase 1 Dose Escalation Study of Bortezomib Combined With Rituximab, Cyclophosphamide, Doxorubicin, Modified Vincristine, and Prednisone for Untreated Follicular Lymphoma and Other Low-Grade B-Cell LymphomasSINHA, Rajni; KAUFMAN, Jonathan L; JO LECHOWICZ, Mary et al.Cancer. 2012, Vol 118, Num 14, pp 3538-3548, issn 0008-543X, 11 p.Article

Early Clearance of Peripheral Blood Blasts Predicts Response to Induction Chemotherapy in Acute Myeloid LeukemiaARELLANO, Martha; PAKKALA, Suchita; LANGSTON, Amelia et al.Cancer. 2012, Vol 118, Num 21, pp 5278-5282, issn 0008-543X, 5 p.Article

Pediatric Cutaneous Angiosarcomas: A Clinicopathologic Study of 10 CasesDEYRUP, Andrea T; MIETTINEN, Markku; NORTH, Paula E et al.The American journal of surgical pathology. 2011, Vol 35, Num 1, pp 70-75, issn 0147-5185, 6 p.Article

A Phase I/II Trial Combining High-Dose Melphalan and Autologous Transplant with Bortezomib for Multiple Myeloma: A Dose- and Schedule-Finding StudyLONIAL, Sagar; KAUFMAN, Jonathan; LECHOWICZ, Mary J et al.Clinical cancer research (Print). 2010, Vol 16, Num 20, pp 5079-5086, issn 1078-0432, 8 p.Article

Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host diseaseAKHTARI, Mojtaba; GIVER, Cynthia R; LONIAL, Sagar et al.Transfusion (Philadelphia, PA). 2010, Vol 50, Num 11, pp 2424-2431, issn 0041-1132, 8 p.Article

Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4POST, Dawn E; SANDBERG, Eric M; KYLE, Michele M et al.Cancer research (Baltimore). 2007, Vol 67, Num 14, pp 6872-6881, issn 0008-5472, 10 p.Article